DiDi Global EBITDA Margin 2021-2025 | DIDIY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for DiDi Global (DIDIY) over the last 10 years. The current EBITDA margin for DiDi Global as of March 31, 2025 is .
| DiDi Global EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $29.23B | $0.47B | 1.61% |
| 2024-12-31 | $28.77B | $0.27B | 0.94% |
| 2024-09-30 | $28.20B | $0.05B | 0.17% |
| 2024-06-30 | $27.76B | $-0.24B | -0.86% |
| 2024-03-31 | $27.71B | $-0.50B | -1.81% |
| 2023-12-31 | $27.10B | $-0.81B | -2.99% |
| 2023-09-30 | $26.93B | $-1.97B | -7.30% |
| 2023-06-30 | $26.27B | $-2.58B | -9.83% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $27.533B | $28.768B |
| DiDi Global Inc. provides mobility technology platform. It offers app-based services across Asia Pacific, Latin America and Africa as well as in Central Asia and Russia, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility as well as auto solutions, food delivery, intra-city freight and financial services. DiDi Global Inc. is based in BEIJING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.378B | 27.33 |
| CVS Health (CVS) | United States | $92.778B | 11.54 |
| Elevance Health (ELV) | United States | $71.753B | 9.65 |
| Cencora (COR) | United States | $56.537B | 18.83 |
| Labcorp Holdings (LH) | United States | $23.101B | 18.36 |
| Natera (NTRA) | United States | $23.092B | 0.00 |
| BioMerieux (BMXMF) | France | $16.600B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.580B | 0.00 |
| ICON (ICLR) | Ireland | $14.370B | 13.83 |
| Medpace Holdings (MEDP) | United States | $13.359B | 35.35 |
| CochLear (CHEOY) | Australia | $12.878B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.08 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.459B | 18.43 |
| Avantor (AVTR) | United States | $9.183B | 13.47 |
| Charles River Laboratories (CRL) | United States | $8.037B | 15.25 |
| Sonic Healthcare (SKHHY) | Australia | $7.750B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.179B | 34.83 |
| Sotera Health (SHC) | United States | $4.650B | 25.98 |
| BrightSpring Health Services (BTSG) | United States | $4.197B | 32.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| GeneDx Holdings (WGS) | United States | $3.720B | 85.19 |
| Alignment Healthcare (ALHC) | United States | $3.240B | 0.00 |
| Concentras Parent (CON) | United States | $3.050B | 19.35 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.449B | 2.67 |
| Premier (PINC) | United States | $2.138B | 19.77 |
| KindlyMD (NAKA) | United States | $2.046B | 0.00 |
| Progyny (PGNY) | United States | $2.035B | 43.04 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.774B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.511B | 25.59 |
| Pediatrix Medical (MD) | United States | $1.499B | 10.01 |
| Teladoc Health (TDOC) | United States | $1.366B | 0.00 |
| Omada Health (OMDA) | $1.364B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.196B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.847B | 4.96 |
| AMN Healthcare Services Inc (AMN) | United States | $0.796B | 9.85 |
| CareDx (CDNA) | United States | $0.727B | 13.39 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.530B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.517B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.488B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| Nutex Health (NUTX) | United States | $0.465B | 7.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.27 |
| Enhabit (EHAB) | United States | $0.399B | 26.27 |
| So-Young (SY) | China | $0.390B | 0.00 |
| Oncology Institute (TOI) | United States | $0.318B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.264B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.173B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.066B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |